Assembly Biosciences ASMB
NASDAQ ASMB
$36.60 +0.47 (+1.30%)
As of: Sep 4, 2026 · 3:59 PM EDT

Assembly Biosciences (ASMB) Interest Coverage Ratio (2010 - 2011)

Assembly Biosciences (ASMB) posted quarterly Interest Coverage Ratio of 1.15 for Q4 2025, up 2210.45% year-over-year from 0.05 in Q4 2024, and up 2210.45% quarter-over-quarter from 0.05 in Q4 2024.

Analysis

Assembly Biosciences (ASMB) Interest Coverage Ratio (2010 - 2011) Analysis & Trends

Assembly Biosciences' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 1.15 for Q4 2025.

  • In Q4 2025, Interest Coverage Ratio rose 2210.45% year-over-year to 1.15; the TTM figure through Dec 2025 stood at 0.7 (down 227.96% YoY), while the FY2025 annual figure was 0.7, down 227.96% from the prior year.
  • Interest Coverage Ratio for Q4 2025 stood at 1.15, up from 0.05 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 1.15 in Q4 2025, with the low at 23401.0 in Q3 2022.
  • The 5-year median for Interest Coverage Ratio is 23.11 (2021), against an average of 2221.27.
  • The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio sank 1000904.9% in 2022, then jumped 2210.45% in 2025.
  • Assembly Biosciences' Interest Coverage Ratio stood at 67.62 in 2021, then soared by 75.23% to 16.75 in 2022, then plunged by 3844.27% to 660.58 in 2023, then jumped by 99.99% to 0.05 in 2024, then surged by 2210.45% to 1.15 in 2025.
  • Business Quant data shows ASMB's Interest Coverage Ratio at 1.15 in Q4 2025, 0.05 in Q4 2024, and 660.58 in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Assembly Biosciences 689.29 Mn 368.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 62.47
Sep 30, 2011 -19.53
Jun 30, 2011 -104.72
Mar 31, 2011 -59.71
Sep 30, 2010 -0.40
Jun 30, 2010 -0.96